Basal cell carcinoma, or BCC, is the most common form of skin cancer globally, but it is also highly curable. This guide is designed to provide newly diagnosed patients with the necessary information ...

Mitch Brummel was diagnosed with Fibrolamellar Carcinoma at just 26 years old. Now, he's fighting for his life.

In October 2025, the U.S. Food and Drug Administration (FDA) granted approval to multiple new cancer therapies and supportive ...

Rates of invasive lobular carcinoma are increasing in the US more than three times faster than those of all other breast cancers. A doctor explains how to lower your risk.

A fast-rising form of breast cancer that’s harder to detect on mammograms now makes up more than one in ten cases in the U.S., according to a new report.

Researchers at The University of Texas MD Anderson Cancer Center, in collaboration with BostonGene, conducted the largest and ...

Immunotherapy with immune checkpoint inhibitors is standard first-line treatment for advanced renal cell carcinoma (RCC), but ...

Whole-genome sequencing (WGS) of tumor and germline can generate actionable molecular insights that can guide precision medicine efforts in salivary gland cancer (SGC), according to a new study in JCO ...

Phio Pharmaceuticals shares were higher after the company reported positive pathology results for its Phase 1b Intasyl PH-762 trial. The stock was 32% higher, at $2.72. Shares are up 55% year to date.

Merck & Co (MSD) and Eisai are set to discontinue their Phase III clinical trial for unresectable, non‑metastatic ...